CSE: UDOC | FRA: L7T | OTCQB: UDOCF
Investor
Presentation
Click To
Download
Investor Presentation
Click To
Download
News
Alerts
Click To
Sign Up
News Alerts
Click To
Sign Up

Category: Corporate

UniDoc Announces LIFE Offering

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / April 4, 2025 / UniDoc Health Corp. (CSE:UDOC) (“UniDoc” or the “Company”) is pleased to announce a non-brokered private placement LIFE offering (the “Offering“) for total gross proceeds of up to $500,000, consisting of up to […]

UniDoc Announces Debt Settlement and Renews Marketing Engagement

VANCOUVER, British Columbia, April 3, 2025 — UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTCQB: UDOCF) (“UniDoc” or the “Company”) announces that it intends to settle $93,240 (equivalent to approximately €60,000) in debt owed to a certain creditor of the Company by issuing approximately 266,400 common shares of the Company at a deemed price of $0.35 […]

UniDoc Completes Purchase of AGNES Connect® Software from AMD Telemedicine

VANCOUVER, British Columbia, March 28, 2025 – UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTCQB: UDOCF) (“UniDoc” or the “Company”), announces that, further to its news release dated March 19, 2025, it has closed the acquisition of the AGNES Connect software from AMD Telemedicine (“AMD”). “The AGNES Connect software forms the foundation of UniDoc’s NEIL Connect software […]

UniDoc Announces Purchase Agreement for AGNES Connect Software from AMD Telemedicine

Strategic Acquisition to Enhance UniDoc’s eHealth Software Capabilities VANCOUVER, BC / March 19, 2025 / UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) (“UniDoc” or the “Company”), an innovator in the eHealth sector, is pleased to announce it has entered into a definitive purchase agreement (the “Agreement”) for the acquisition of the AGNES Connect software from AMD Telemedicine (“AMD”). This software […]

UniDoc – Announces Filing of Amended and Restated Interim Management Discussion and Analysis

VANCOUVER, BC / February 24, 2025 / UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) (“UniDoc” or the “Company“), is issuing this news release to advise its shareholders that the Company has been subject to a continuous disclosure review by the British Columbia Securities Commission. In connection therewith, the Company has filed amended and restated management’s discussion and analysis (“MD&A“) […]

UniDoc – Company Recognizes Initial Revenue on Delivery of AI-Equipped H3 Health Cubes

Three customers take delivery at year end VANCOUVER, British Columbia, January 09, 2025 — UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTCQB: UDOCF) (“UniDoc,” or the “Company”), an innovator in the eHealth sector, is pleased to announce, in furtherance to its press release dated November 6, 2024, that the initial AI-assisted H3 Health Cubes, for […]

UniDoc Health Corp. Reflects on a Year of Growth and Innovation

Strategic Partnerships and AI Integration Position UniDoc as an eHealth Solution VANCOUVER, British Columbia, December 17, 2024 — UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTCQB: UDOCF) (“UniDoc,” or the “Company”), an innovator in the eHealth sector, is proud to present its year in review, highlighting a series of achievements that underscore its progress toward […]

UniDoc Showcases H3 Health Cube in Italy

AI-equipped H3 Health Cube Displayed at the Annual Assembly of the National Association of Italian Municipalities VANCOUVER, British Columbia, Nov 20, 2024 — UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTCQB: UDOCF) (“UniDoc,” or the “Company”), an innovator in the eHealth sector, is pleased to announce that its H3 Health Cube has been selected to […]

UniDoc Ships First AI-Equipped H3 Health Cubes to Commercial Customers

Three Shipments Mark Progress in eHealth Deployment VANCOUVER, British Columbia, November 6, 2024 — UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTCQB: UDOCF) (“UniDoc,” or the “Company”), an innovator in the eHealth sector, is pleased to announce the initial shipment of its first AI-assisted H3 Health Cubes, for three commercial orders. These orders include units […]

UniDoc Health to Attend HLTH 2024 as Part of S&P500 TelCo’s Booth

— Integrating Advanced eHealth Solutions with the Latest Telecommunications Services VANCOUVER, British Columbia, October 02, 2024 — UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTCQB: UDOCF) (“UniDoc,” or the “Company”), an innovator in the eHealth sector, is pleased to announce its participation in the HLTH 2024 conference as part of the booth of one of […]

CSE: UDOC | FRA: L7T | OTCQB: UDOCF
Investor Presentation

Subscribe to News Alerts

By submitting the form, you agree to receive communications from UniDoc Health.

Consent*

UniDoc Health Corp. © 2025. All rights reserved.

Sign Up For News Alerts

Enter your details below and we will add you to our News Alerts list.

Consent(Required)

Austin Thornberry

Director

Mr. Thornberry is a seasoned finance professional with a background in advising new companies in the venture capital market. He brings extensive experience working with high-growth companies across numerous industries through his past work in the technology and innovation banking group at the Bank of Montreal and in the financial services arm of Ernst & Young advising on multiple capital markets transactions. Mr. Thornberry has split his time working in Toronto, Ont., and Vancouver, B.C. He obtained his bachelor of commerce at McGill University and has held the CPA, CA, designation since 2019.

Matt Chatterton

DIRECTOR

Mr. Chatterton brings over 18 years of experience in development and execution of complex projects. His  expertise includes project management, facility management, logistics, and supply side processes and  procedures at a number of operations in Canada and internationally. He has  been involved in the public markets for the last three years managing IPO processes and transitioning  businesses to post listing operations. Mr. Chatterton is a Professional Engineer and graduate of  Canada’s Queens University with a Bachelor’s degree in Engineering Chemistry (2001) and Master’s degree in Chemical Process Engineering (2003).

Sina Pirooz

Director

Mr. Pirooz is a registered and practicing pharmacist, and has been a professional member of the College of Pharmacists of British Columbia since 2003, with over 20 years of pharmaceuticals and pharmacy management experience. As owner of a compounding pharmacy, Mr. Pirooz has been dispensing pharmaceuticals for over 18 years and provides pharmacist and pharmacy management services to many of Canada’s largest pharmacy chains and drug stores. Mr. Pirooz is also the CEO and a director of Genix Pharmaceuticals Corporation, a company listed for trading on the TSXV.

Dr. Sazzad Hossain, PhD

Chief Scientific Officer

He is the former Chief Scientific Officer of InMed Pharmaceuticals Inc., a leading public Canadian bio-pharmaceutical company. Previously he worked as Senior Scientist at Biotechnology Research Institute of National Research Council Canada. Working with the Canadian government he helped establish the pharmacology laboratory to evaluate safety and efficacy of cannabinoid-based and other drugs under development for cancer, cardiovascular and ocular diseases.

Jacob Moshinsky

Chief Operating Officer

Jacob is the CEO & founder of MoviWear a GPS, fall down detection & remote vital-sign monitoring platform, alerting caregivers of real-time emergencies. Jacob is a communications and technology expert with over 15 years’ experience in the field. the NurtureWatch health monitoring Smartwatch and MoviWearMED remote vital sign monitoring platform Prior to MoviWear, Jacob worked in both the Canadian telecom and the CPG industry. He led the Product Development and Business Strategy team at TELUS for the Small Business Portfolio. Jacob also worked in various product and service management roles within Rogers Communications where he launched and managed wireless and wireline products.

Antonio Baldassarre

CEO, President and Director

Mr. Baldassarre has held senior management and director positions of new business start-ups and established multinational organizations with over 30 years of experience in the Security, Information Technology and Communications industries. With leadership skills in management of international operations, shareholder exit strategies, and overall business development, he has utilized a wide range of strategic programs to maximize organic growth into specific industry segments through OEM, alliances, and direct multi-level distribution channels.

Mr. Baldassarre is able to plan, organize and direct all aspects of a Corporation from Operations, P&L oversight, product distribution, Product promotions, sales and development activities and initiatives utilizing my extensive marketing/sales senior management experience with developed abilities in team leadership and program/campaign development. Directly involved in the growth, branding and ultimately optimizing market share, product awareness, revenues, profitability and shareholder value.

Mr. Baldassare is also the President of LRG Security Canada Inc. and LRG Security Europe.

Franco Staino

DIRECTOR

Mr. Franco Staino is a business professional with over 40 years experience in the pharmaceutical industry. Mr. Staino has significant experience in drug safety, traceability and anti-counterfeiting measures and has designed and implemented programs for the Italy National Health Service, the Ministry of Health and the Polygraphic Institute and State Mint.

Mr. Staino currently holds multiple positions including being the control representative of Carlucci a leading company engaged in the production of self-adhesive labels for consumer goods with high specialization for the pharmaceutical sector, and President of the Board of Directors of Topharmacia, a company that deals with the integral management of pharmacies throughout Italy in order to improve their ability to provide social and commercial services, to connect industrial marketing policy to that of the pharmacy, to offer tools in able to guarantee the financial balance of the companies involved.